IPO - Renaissance IPO ETF
| Previous Close | 29.99 |
| Open | 30.00 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 1400 |
| Day's Range | 30.00 - 30.00 |
| 52 Week Range | 25.23 - 31.67 |
| Volume | 385 |
| Avg. Volume | 5,817 |
| Net Assets | 19.25M |
| NAV | 29.62 |
| PE Ratio (TTM) | N/A |
| Yield | 0.38% |
| YTD Return | 5.05% |
| Beta (3y) | 1.14 |
| Expense Ratio (net) | 0.60% |
| Inception Date | 2013-10-16 |
- MarketWatch•17 days ago
Arlo stock jumps after IPO
MARKET PULSE Shares of Arlo Technologies Inc. (arlo) are up 18% in Friday morning trading, after the company went public on the New York Stock Exchange. The stock is trading above its IPO price of $16.
- Investopedia•18 days ago
Saudi Women Drive Economic Boom
In ending its ban on female drivers, the Saudi Arabian government has implemented a change that many believe will lead to significant positive impacts on the kingdom's economy. The end of the ban, effective June 24, 2018, is a part of the kingdom's Vision 2030 program of reform. Other aspects of Vision 2030 are focused on human rights.
- MarketWatch•18 days ago
Sonos stock rises after IPO
MARKET PULSE Shares of Sonos Inc. (sono) rose 4.3% in Thursday morning's session, the stock's first day of trading. The first trade was executed for $16 at 11:14 a.m. ET. Shares are currently trading above the IPO price of $15 but below the opening price as well as Sonos' initially expected pricing range of $17 to $19.
- MarketWatch•18 days ago
Cushman & Wakefield's stock opens nearly 6% above IPO price
MARKET PULSE Cushman & Wakefield PLC's stock (cwk) opened 5.9% above its initial public offering price, as the real estate services company raised at least $765 million. The first trade was at $18 at 10:18 a.
- MarketWatch•29 days ago
Cushman & Wakefield sets terms of IPO, to raise up to $810 million
Cushman & Wakefield (cwk) set terms for its initial public offering, in which the commercial real estate services company seeks to raise up to $810 million, and which would value the company at up to $3.57 billion. The company, which is offering 45 million shares, expects the IPO to price between $16 and $18 a share. The company plan for its stock to list on the NYSE under the ticker symbol "CWK." The lead underwriters are Morgan Stanley, J.P. Morgan, Goldman Sachs and UBS.
- MarketWatch•last month
Constellation Pharmaceuticals IPO prices at midpoint, but shares offered cut by 25%
Constellation Pharmaceuticals Inc. (cnst) priced its initial public offering late Wednesday right in the middle of the expected range, but cut the size of its offering by 25%. The IPO priced at $15 a share, according to Nasdaq, but the shares offered was reduced to 4.0 million from the 5.34 million, to raise $60 million instead of $80.1 million. The biotechnology company is developing cancer therapies that modulate abnormal genes.
- MarketWatch•last month
Ridesharing company YayYo sets terms of IPO to raise up to $11.3 million
YayYo Inc. (yayo) disclosed Wednesday terms of its initial pubic offering, in which the ridesharing and taxi services company could raise up to $11.25 million. The Beverly Hills, Calif.-based said it is offering 1.25 million shares of common stock, with the IPO expected to price between $7 and $9 a share. YayYo expects the stock to list on the Nasdaq Capital Market under the ticker symbol "YAYO." The company reported a gross profit of $22,579 in 2017 and revenue of $235,690.
- MarketWatch•last month
IPO market faces busy week that includes first cannabis cultivator to list on Nasdaq
A Canadian cannabis company, an oil-and-gas services company, two banks and a smattering of biotechs are among the 10 companies that are expected to complete their initial public offerings this week to mark one of the busiest weeks of the year.
- MarketWatch•last month
IPO boom has opened the window for some scary companies
A stunning number of companies are trying to jump through the current hot market for initial public offerings, but investors would be wise to watch for rats hoping to sneak in amid the torrent.
- InvestorPlace•last month
5 ETFs to Play in July
As promised, President Donald Trump confirmed that he will fire the first shot in the trade war against China by levying tariffs on $34 billion of Chinese imports starting today, triggering almost sure-shot chances of retaliations. Not only China, the European Union is also prepared to cap its imports of steel as part of a knock-on effect of Trump’s protectionism.Source: A Closer Listen
- Zacks•last month
5 ETFs to Play in July
Investors may tap these five ETFs for gains as President Trump aims the first shot in the trade war.
- MarketWatch•last month
Rubius Therapeutics sets terms of IPO, which could value the company at up to $1.7 billion
Rubius Therapeutics (ruby) set terms of its initial public offering, which is expected to raise up to $209.7 million. The company, which develops red blood cellular therapies, said it is offering 9.53 million shares in its IPO, which is expected to price between $20 and $22 a share. If the underwriters exercise all the options to buy additional shares, Rubius could raise up to $241.1 million.
- InvestorPlace•last month
U.S. IPO Market Stages Solid Comeback: ETFs to Bet On
After two lackluster years, the U.S. IPO market has made an impressive comeback this year, with companies raising capital at a pace seen in the past two decades.Source: Shutterstock
- MarketWatch•last month
Smart home audio company Sonos files to go public
Sonos Inc., the smart home sound system company, filed Friday to go public. The company has applied to be listed on the Nasdaq Global Select Market under the ticker symbol "SONO." The company said it plans to raise up to $100 million in the initial public offering, but that amount was estimated as a placeholder amount.
- MarketWatch•2 months ago
I3 Verticals stock soars after IPO
MARKET PULSE Shares of I3 Verticals Inc. (iiiv) have soared 42% in Thursday trading, following the payments company's initial public offering. I3 priced its IPO at $13 a share late Wednesday, and shares are now trading above $18.
- MarketWatch•2 months ago
Eidos Therapeutics stock soars in debut
Shares of Eidos Therapeutics Inc. are up 16% in Wednesday morning trading, after the clinical stage biopharmaceutical company debuted its stock on the Nasdaq. The company priced its IPO late Tuesday at ...
- MarketWatch•2 months ago
Eidos Therapeutics stock soars in debut
MARKET PULSE Shares of Eidos Therapeutics Inc. (eidx) are up 16% in Wednesday morning trading, after the clinical stage biopharmaceutical company debuted its stock on the Nasdaq. The company priced its IPO late Tuesday at $17 a share and the stock is currently trading near $19.
- MarketWatch•2 months ago
Much-hyped cloud startup Domo looks like a tech IPO to avoid
Domo Inc. is a highly funded unicorn cloud company that has burned through most of its cash and is now going to the public markets looking for more. Headquartered in American Fork, Utah, Domo (IPO:DOMO) describes itself as a cloud service that lets CEOs run their businesses from their smartphones, using data analytics. Domo has not yet specified the timing for its deal, which is being underwritten by Wall Street powerhouses including Morgan Stanley and Credit Suisse.
- MarketWatch•3 months ago
GreenSky stock stalls after IPO, but CEO sees new growth levers ahead
CEO David Zalik told MarketWatch that plans to expand into new verticals are ‘currently in development’GreenSkyGreenSky CEO David Zalik said that investors seemed attracted to the company's blend of scale, profits and growth. After two years of a relative drought for financial-technology initial public offerings, GreenSky Inc. made its public debut Thursday. GreenSky (GSKY) enables consumer loans at the point of sale, and its IPO is being closely watched by other industry players that may be considering their own offerings but want to first find out if the market will be welcoming.
